| 08:30 - 10:30 | 35 | ERS Paediatric Respiratory Research Awards in Europe Ceremony (supported by Merck) followed by Paediatric Grand Round - an interactive session | Grand round |
| 08:30 - 10:30 | 36 | Live and let dive: diving and lung health | Symposium |
| 08:30 - 10:30 | 37 | Small airways: important in COPD and severe asthma | Symposium |
| 08:30 - 10:30 | 38 | Prognostic and predictive factors in lung cancer | Symposium |
| 08:30 - 10:30 | 39 | The burden of pulmonary hypertension in respiratory disease | Symposium |
| 08:30 - 10:30 | 40 | Fixed ratio or other ways to define COPD: what can we learn from others? | Hot topics |
| 08:30 - 10:30 | 41 | The COPD patient experience: care and management | Oral Presentation |
| 08:30 - 10:30 | 42 | New insights in the treatment of idiopathic pulmonary fibrosis | Oral Presentation |
| 08:30 - 10:30 | 43 | Early diagnosis in primary care | Oral Presentation |
| 08:30 - 10:30 | 44 | Smoking cessation science | Oral Presentation |
| 08:30 - 10:30 | 45 | Mechanisms and outcomes of infective exacerbations of COPD | Oral Presentation |
| 08:30 - 10:30 | 46 | Skeletal muscle weakness in COPD: physical (in)activity and biological markers | Oral Presentation |
| 08:30 - 10:30 | 47 | Macrophages and neutrophils in chronic lung disease | Oral Presentation |
| 08:30 - 10:30 | 48 | Immunobiology in the transplanted lung: experimental and clinical evaluations | Oral Presentation |
| 08:30 - 10:30 | 49 | Are needles really enough? | Poster Discussion |
| 08:30 - 10:30 | 50 | COPD management | Poster Discussion |
| 08:30 - 10:30 | 51 | Allergen immunotherapy and anti-immunoglobulin E | Poster Discussion |
| 08:30 - 10:30 | 52 | Physical activity, methodology and impact | Poster Discussion |
| 08:30 - 10:30 | 53 | Tuberculin skin tests, interferon-gamma release assays and beyond | Poster Discussion |
| 08:30 - 10:30 | 54 | Genetic and environmental risk factors for respiratory diseases | Poster Discussion |
| 10:45 - 12:45 | 57 | Sadoul Lecture followed by a session of Assembly 9: How to get the best signal? | Sadoul Lecture |
| 10:45 - 12:45 | 59 | Macrophage heterogeneity in respiratory diseases | Symposium |
| 10:45 - 12:45 | 60 | Mechanical ventilation: the American versus the European approach | Symposium |
| 10:45 - 12:45 | 61 | Novelties in lung transplantation | Symposium |
| 10:45 - 12:45 | 62 | New advances in smoking cessation | Symposium |
| 10:45 - 12:45 | 63 | Mechanism and monitoring of airway diseases | Oral Presentation |
| 10:45 - 12:45 | 64 | Cystic fibrosis: New aspects of diagnosis, inflammation and detecting exacerbation | Oral Presentation |
| 10:45 - 12:45 | 65 | Endoscopic lung volume reduction: hype or hope? | Oral Presentation |
| 10:45 - 12:45 | 66 | Altered mechanisms during exercise in disease | Oral Presentation |
| 10:45 - 12:45 | 67 | Treatment of lung cancer | Oral Presentation |
| 10:45 - 12:45 | 68 | Multidrug-resistant tuberculosis | Oral Presentation |
| 10:45 - 12:45 | 69 | Diagnosis and predictors of COPD exacerbation | Oral Presentation |
| 10:45 - 12:45 | 70 | Treatments for pulmonary hypertension in human and experimental models | Oral Presentation |
| 10:45 - 12:45 | 71 | Recent developments in COPD | Poster Discussion |
| 10:45 - 12:45 | 72 | Genetics of airway diseases and treatment | Poster Discussion |
| 10:45 - 12:45 | 73 | Pleural diseases and pneumothorax | Poster Discussion |
| 10:45 - 12:45 | 74 | Biomarkers of allergic inflammation | Poster Discussion |
| 10:45 - 12:45 | 75 | The new clinical spectrum of lung diseases: from bronchi to pleura | Poster Discussion |
| 10:45 - 12:45 | 76 | Innate and exogenous factors in childhood respiratory infection | Poster Discussion |
| 12:50 - 14:40 | 78 | Asthma: a heterogeneous disease | Thematic Poster Session |
| 12:50 - 14:40 | 79 | COPD management | Thematic Poster Session |
| 12:50 - 14:40 | 80 | COPD exacerbation | Thematic Poster Session |
| 12:50 - 14:40 | 81 | Vascular and parenchymal imaging | Thematic Poster Session |
| 12:50 - 14:40 | 82 | From outside to inside: access to the pleura | Thematic Poster Session |
| 12:50 - 14:40 | 83 | To stent or not to stent: interventional bronchoscopy | Thematic Poster Session |
| 12:50 - 14:40 | 84 | Rare diffuse lung diseases | Thematic Poster Session |
| 12:50 - 14:40 | 85 | What is new in the approach to pulmonary fibrosis? | Thematic Poster Session |
| 12:50 - 14:40 | 86 | Experimental models and research in diffuse parenchymal lung diseases | Thematic Poster Session |
| 12:50 - 14:40 | 87 | Quality of life and respiratory symptom management in primary care | Thematic Poster Session |
| 12:50 - 14:40 | 88 | New mechanisms in airway disease | Thematic Poster Session |
| 12:50 - 14:40 | 89 | COPD: human studies | Thematic Poster Session |
| 12:50 - 14:40 | 90 | Airway smooth muscle cells and fibroblasts: cell biology | Thematic Poster Session |
| 12:50 - 14:40 | 91 | Lung cell biology | Thematic Poster Session |
| 12:50 - 14:40 | 92 | The ageing pulmonary interstitium | Thematic Poster Session |
| 12:50 - 14:40 | 93 | Anti-inflammatory strategies in acute lung injury | Thematic Poster Session |
| 12:50 - 14:40 | 94 | Drug delivery and pharmacokinetics I | Thematic Poster Session |
| 12:50 - 14:40 | 95 | Translational models of disease | Thematic Poster Session |
| 12:50 - 14:40 | 96 | Bronchodilators in asthma and COPD | Thematic Poster Session |
| 12:50 - 14:40 | 97 | Asthma: control and treatment | Thematic Poster Session |
| 12:50 - 14:40 | 98 | Monitoring exacerbations of airway diseases | Thematic Poster Session |
| 12:50 - 14:40 | 99 | Monitoring with lung function tests in airway diseases | Thematic Poster Session |
| 12:50 - 14:40 | 100 | Clinical parameters in airway diseases | Thematic Poster Session |
| 12:50 - 14:40 | 101 | Animal models of airway inflammation | Thematic Poster Session |
| 12:50 - 14:40 | 102 | Asthma: risk factors and comorbidities | Thematic Poster Session |
| 12:50 - 14:40 | 103 | Respiratory epidemiology: genetics and modifiable risk factors | Thematic Poster Session |
| 12:50 - 14:40 | 104 | Respiratory epidemiology: comorbidity | Thematic Poster Session |
| 12:50 - 14:40 | 105 | Air pollution | Thematic Poster Session |
| 12:50 - 14:40 | 106 | Mineral dusts | Thematic Poster Session |
| 12:50 - 14:40 | 107 | Smoking cessation science and smoking-related disorders | Thematic Poster Session |
| 12:50 - 14:40 | 108 | Smoking rate: smoking cessation interventions | Thematic Poster Session |
| 12:50 - 14:40 | 109 | New insights in paediatric respiratory physiology | Thematic Poster Session |
| 12:50 - 14:40 | 110 | Risk and detection of childhood asthma and allergy | Thematic Poster Session |
| 12:50 - 14:40 | 111 | Paediatric respiratory infection: signs, symptoms and sequelae | Thematic Poster Session |
| 12:50 - 14:40 | 112 | Paediatric epidemiology: bronchiolitis, pneumonia, asthma and spirometry in non-respiratory conditions | Thematic Poster Session |
| 12:50 - 14:40 | 113 | Lung function today and tomorrow I | Thematic Poster Session |
| 12:50 - 14:40 | 114 | Lung function today and tomorrow II | Thematic Poster Session |
| 12:50 - 14:40 | 115 | Exercise tests and emerging outcomes: defining the impact of pulmonary rehabilitation | Thematic Poster Session |
| 12:50 - 14:40 | 116 | Exacerbations and severe chronic respiratory disease: oxygen, rehabilitation, admission to hospital and palliative care | Thematic Poster Session |
| 12:50 - 14:40 | 117 | Rehabilitation, outcome measures and effects | Thematic Poster Session |
| 12:50 - 14:40 | 118 | Respiratory physiotherapy in the intensive care unit and on the ward: breathing exercises and respiratory muscles | Thematic Poster Session |
| 12:50 - 14:40 | 119 | Asthma: issues in rehabilitation and physical therapy | Thematic Poster Session |
| 12:50 - 14:40 | 120 | The eclectic world of respiratory nursing | Thematic Poster Session |
| 13:00 - 14:15 | 121 | Lancet / ERS symposium - New frontiers in COPD | Symposium |
| 13:00 - 14:15 | 122 | The European Respiratory Review 2010 updates: whats hot in pulmonary medicine? | Symposium |
| 13:00 - 14:30 | 123 | Optimising healthcare for COPD across Europe | Symposium |
| 13:00 - 14:15 | 124 | BMJ/ERJ Symposium – Peer reviewing | Symposium |
| 14:45 - 16:45 | 145 | Interventional Pneumology Grand Round - an interactive session | Grand round |
| 14:45 - 16:45 | 146 | New promising ways to treat cystic fibrosis | Symposium |
| 14:45 - 16:45 | 147 | Acute breathlessness: the state of the science | Symposium |
| 14:45 - 16:45 | 148 | TBNET: tuberculosis research in Europe | Symposium |
| 14:45 - 16:45 | 149 | Knowing COPD by heart: a relationship beyond comorbidity | Symposium |
| 14:45 - 16:45 | 150 | Accelerated lung ageing in COPD | Symposium |
| 14:45 - 16:45 | 151 | Mechanisms of allergic inflammation of the airways | Oral Presentation |
| 14:45 - 16:45 | 152 | Dilemmas and progress in understanding childhood asthma | Oral Presentation |
| 14:45 - 16:45 | 153 | Flexible bronchoscopy in the diagnosis of paediatric lung diseases | Oral Presentation |
| 14:45 - 16:45 | 154 | Physiology and cardiometabolic comorbidities in obstructive sleep apnoea | Oral Presentation |
| 14:45 - 16:45 | 155 | Advances in long-term noninvasive positive pressure ventilation | Oral Presentation |
| 14:45 - 16:45 | 156 | Functional lung and pulmonary arterial imaging | Oral Presentation |
| 14:45 - 16:45 | 157 | Epithelial cells: role in health and disease | Oral Presentation |
| 14:45 - 16:45 | 158 | Exercise training: new populations, new techniques | Oral Presentation |
| 14:45 - 16:45 | 159 | Biomarkers and outcomes of community-acquired pneumonia | Poster Discussion |
| 14:45 - 16:45 | 160 | Progress in pathology of lung cancer | Poster Discussion |
| 14:45 - 16:45 | 161 | Paediatric epidemiology: predicting outcomes of wheeze, antenatal growth, early life exposures and outcome of premature birth | Poster Discussion |
| 14:45 - 16:45 | 162 | Clinical characteristics of patients with pulmonary hypertension | Poster Discussion |
| 14:45 - 16:45 | 163 | Exercise assessment in different diseases | Poster Discussion |
| 14:45 - 16:45 | 164 | Smoking-related disorders and smoking prevention | Poster Discussion |
| 17:15 - 18:45 | 185 | The 2011 PAH debate: what is the biggest challenge we face to optimise patient outcome? | Evening Symposium |